This webinar is part of Bioprocess Webinar Series. See other webinars in this series on our webinar page - Advanced Trends and Tools for Immune Cell Therapy and Advanced Trends and Tools for Stem Cell Therapy.
Once considered conceptual, gene therapy has now become a reality, and as this therapy becomes more widely adopted, the need for larger batch sizes will ultimately conflict with the amount of available space in clean rooms. Building on a long and expert history in cell culture, Corning offers viral vector manufacturing platforms that are easily integrated into modular production set-ups, such as Corning® HYPERStack® and CellSTACK® vessels, which are enabling viral vectors to be produced at large scales. This seminar will introduce you to the new tools and solutions that Corning has developed for this field, as well as applications related to viral vector production.
Presenter bio:
After graduating from Biochemistry from the University of Santiago (Chile), Constanza perused a career in the Chilean animal health industry, developing as a Bioprocess Scientist for vaccine production in charge of scale-up and tech transfer. She furthered developed her career in Belgium, in the field of antibody production in suspension cell lines. Constanza is currently a Field Application Scientist for the EMEA region, providing customers in-depth technical support, presenting seminars and trainings, and assisting customers in experimental set-up and troubleshooting.